Jeffrey S Sklar (Jeffrey Sklar)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Metastatic Colorectal Cancer

Gene Expression

Top Venues

Cancer research communications

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey S Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kortmansky, Kimberly L Johung, Ranjit S Bindra, Patricia M LoRusso, Kurt A Schalper
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer research communications 3 (6) (2023)
Joseph Paul Eder, Deborah B Doroshow, Khanh T Do, Vicki L Keedy, Jeffrey S Sklar, Peter M Glazer, Ranjit Bindra, Geoffrey I Shapiro
Clinical Efficacy of Olaparib in IDH1/IDH2- Mutant Mesenchymal Sarcomas. JCO precision oncology 5 (2022)
Haider Mahdi, Navid Hafez, Deborah B Doroshow, Davendra Sohal, Vickie Keedy, Khanh T Do, Patricia LoRusso, Juliane Jürgensmeier, Manuel Avedissian, Jeffrey S Sklar, Colin Glover, Brunella Felicetti, Emma Dean, Peter G S Mortimer, Geoffrey I Shapiro, Joseph Paul Eder
Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations). JCO precision oncology 5 (2021)